IGI Laboratories, Inc. has entered into a three-year agreement with Juventio, LLC to manufacture and supply finished dose forms of certain cosmetic and OTC products and formulations owned and developed by IGI. The products use IGI’s encapsulation technology Novasome. Juventio, based in NJ, distributes non-prescription health products, in partnership with healthcare professionals.   Jason Grenfell-Gardner, president and chief executive officer of IGI, said, “We are excited to partner with Juventi...